Ex-vivo activation of natural killer (NK) cell effector by cetuximab (CTX) is effective in patients (pts) with colorectal cancer (CRC)
EUROPEAN JOURNAL OF CANCER（2013）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined